The diagnosis of insulinoma is established by demonstrating inappropriately high serum insulin, C-peptide, and proinsulin concentrations without evidence of sulfonylurea use during a spontaneous or provoked episode of hypoglycemia [15]. The gene discussed is INS; the disease is Hypoglycemia.